Corneal transplantation remains a challenge within developing countries due to a lack of donor tissue and underdeveloped infrastructure. May Griffith, PhD, University of Montreal & Hopital Maisonneuve-Rosemont, Montreal, Canada, discusses the development of LiQD Cornea, a alternative to corneal transplantation in patients. Whereas other similar therapies require preparation of the pregel in a lab, LiQD Cornea gels within the cornea itself. The ease of administration will enable easier access to corneal treatments within the developing world, and mouse models have indicated preliminary efficacy. This interview took place at the 6th World Congress of the Tissue Engineering and Regenerative Medicine International Society (TERMIS 2021).